ALOPI MODI: Open Payments
NPI 1164267498 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,857 in 82 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $599 · 2025 $1,857
Food & beverage: $1,857
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $433 |
| Ardelyx, Inc. | 11 | $290 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $168 |
| Regeneron Healthcare Solutions, Inc. | 2 | $155 |
| GENZYME CORPORATION | 9 | $154 |
| Madrigal Pharmaceuticals | 6 | $138 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $103 |
| Aimmune Therapeutics, Inc. | 5 | $102 |
| Phathom Pharmaceuticals, Inc. | 7 | $83 |
| Novo Nordisk Inc | 2 | $69 |
Products named: DUPIXENT, IBSRELA, RINVOQ, REZDIFFRA, ENTYVIO, XIFAXAN, ZENPEP, VOQUEZNA.
Industry payments across NC — which companies pay providers there.
